Item 7.01 Regulation FD Disclosure.

Yumanity Therapeutics, Inc. (the "Company") intends to participate in the H.C. Wainright Virtual BioConnect Conference on January 11, 2021. A copy of the Company's slide presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits.



Exhibit
  No.       Document

99.1          Yumanity Therapeutics, Inc. slide presentation, dated January 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses